CHRISTINA LEE: Open Payments
NPI 1902150659 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 57 payments from 20 companies in 2025. Trend: 2023 $1,090 · 2024 $1,095 · 2025 $1,606
Food & beverage: $1,601Education: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $328 |
| ConvaTec Inc. | 6 | $211 |
| Janssen Biotech, Inc. | 3 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $161 |
| Novartis Pharmaceuticals Corporation | 3 | $100 |
| Endo USA, Inc. | 3 | $75 |
| Boston Scientific Corporation | 2 | $69 |
| UROGEN PHARMA, INC. | 2 | $68 |
| Teleflex LLC | 2 | $61 |
| Merck Sharp & Dohme LLC | 2 | $51 |
Products named: GENTLECATH, ERLEADA, ORGOVYX, Nubeqa, GEMTESA, PLUVICTO, KEYTRUDA, XIAFLEX.
Industry payments across CO — which companies pay providers there.
